<SEC-DOCUMENT>0001140361-22-030333.txt : 20220819
<SEC-HEADER>0001140361-22-030333.hdr.sgml : 20220819
<ACCEPTANCE-DATETIME>20220819091310
ACCESSION NUMBER:		0001140361-22-030333
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20220818
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220819
DATE AS OF CHANGE:		20220819

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CATALYST BIOSCIENCES, INC.
		CENTRAL INDEX KEY:			0001124105
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				562020050
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51173
		FILM NUMBER:		221179136

	BUSINESS ADDRESS:	
		STREET 1:		611 GATEWAY BLVD., SUITE 710
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650-871-0761

	MAIL ADDRESS:	
		STREET 1:		611 GATEWAY BLVD., SUITE 710
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TARGACEPT INC
		DATE OF NAME CHANGE:	20000919
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>brhc10041057_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:cbio="http://ir.catalystbiosciences.com/20220818" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 22.7.2.5062
         Copyright 1995 - 2022 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_6644283189c6493d8852ac87ae305779" contextRef="c20220818to20220818" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_b2e129b36b124c65bf318047ef78c84a" contextRef="c20220818to20220818">0001124105</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="cbio-20220818.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20220818to20220818"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124105</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-18</xbrli:startDate><xbrli:endDate>2022-08-18</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div><span style="font-size: 10pt;"> </span></div>

  <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
  <div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: 400;"> <br />
    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_3204267b8d6646feb9d4c5d04ebeaa03" contextRef="c20220818to20220818">8-K</ix:nonNumeric></div>

    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: 400;"> <br />
    </div>

    <div style="font-size: 10pt;">
      <div>
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 or 15(d)</div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">of the Securities Exchange Act of 1934</div>

    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_db83e61ebee9430cb481a5fc3f95b847" contextRef="c20220818to20220818" format="ixt:datemonthdayyearen">August 18, 2022</ix:nonNumeric></div>

    <div>
      <div style="font-size: 10pt;"><br />
      </div>

      <div style="font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    </div>

    <div style="text-align: center; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_de1d1d84b0c84df9ae7a5ed69e89be8b" contextRef="c20220818to20220818">CATALYST BIOSCIENCES, INC.</ix:nonNumeric></div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Exact name of registrant as specified in its charter)</div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br />
    </div>

    <div>
      <div style="font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

      <div style="font-size: 10pt;">&#160;</div>

    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33%; vertical-align: top; font-size: 10pt; text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_9c2e43013af049a8a4fabe5174e900d3" contextRef="c20220818to20220818" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br />
          </td>

    <td style="width: 34%; vertical-align: top; font-size: 10pt; text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_74c50385d3f841e58993bc8c2fae387a" contextRef="c20220818to20220818">000-51173</ix:nonNumeric><br />
          </td>

    <td style="width: 32.63%; vertical-align: top; font-size: 10pt; text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_b56115757e924c8180834dc75a1497af" contextRef="c20220818to20220818">56-2020050</ix:nonNumeric><br />
          </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(State or other jurisdiction of incorporation)</div>
          </td>

    <td style="width: 34%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Commission File Number)</div>
          </td>

    <td style="width: 32.63%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(IRS Employer Identification No.)</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_de59ee36179f4ee8a53a4bafdee7af49" contextRef="c20220818to20220818">611 Gateway Blvd, Suite 710</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_aebbebe7b27c411289e14c2355b7dd07" contextRef="c20220818to20220818">South San Francisco</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_d9c09fde118d4120bf795280f5d5a847" contextRef="c20220818to20220818">CA</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_e95ad50c2b81421096440a3bd2e8dcd4" contextRef="c20220818to20220818">94080</ix:nonNumeric></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Address of principal executive offices)</div>

    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_2ce1ecfb90cc463d84848c66ac5e9914" contextRef="c20220818to20220818">650</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_d671054e6f994e0a818d09800b0a2d45" contextRef="c20220818to20220818">871-0761</ix:nonNumeric></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Registrant&#8217;s telephone number, including area code)</div>

    <div style="font-size: 10pt;"><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Not Applicable</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(<span style="font-family: 'Times New Roman'; font-weight: bold;">Former name or former address, if changed since last report.)</span></div>

    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</div>

    <div style="text-align: left;">
<div><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> </span><br /></div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 27pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_83d19f365e3d4169ab23f73a8293b8c5" contextRef="c20220818to20220818" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
              </td>

    <td style="align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
              </td>

  </tr>


</table>
      </div>

      <div style="text-align: left;"><br />
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 27pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_1bab9b798b76421db6f6bfc0bd775135" contextRef="c20220818to20220818" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></td>

    <td style="align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
              </td>

  </tr>


</table>
      </div>

      <div style="text-align: left;"><br />
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 27pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_0ae1ba9c29b04c28bfea156edb0b678a" contextRef="c20220818to20220818" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></td>

    <td style="align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
              </td>

  </tr>


</table>
      </div>

      <div style="text-align: left;"><br />
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 27pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_9dd5575f7c6148b08d750d5c8d400658" contextRef="c20220818to20220818" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
              </td>

    <td style="align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
              </td>

  </tr>


</table>
      </div>

    </div>

  </div>

  <div>
<div><span style="font-size: 10pt;"><br />
    </span></div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

    <div style="font-size: 10pt;"><br />
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Title of each class</div>
          </td>

    <td style="width: 34%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Trading Symbol(s)</div>
          </td>

    <td style="width: 33%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Name of each exchange on which registered</div>
          </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_51454fcffd5c4c6e9964803150da6a88" contextRef="c20220818to20220818">Common Stock</ix:nonNumeric><br />
          </td>

    <td style="width: 34%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_359b14bedb1447e9a6856db0e4763616" contextRef="c20220818to20220818">CBIO</ix:nonNumeric><br />
          </td>

    <td style="width: 33%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_6303330463e242c4b4fd9445e61f2a40" contextRef="c20220818to20220818" format="ixt-sec:exchnameen">Nasdaq</ix:nonNumeric><br />
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (<span style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#167;</span> 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (<span style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#167;</span> 240.12b-2 of this chapter).</div>

    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_0636e19b1b87467e98d6a8d3487dc284" contextRef="c20220818to20220818" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>

    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
      financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /> </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 63pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 8.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">Other Events.</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">On August 18, 2022 (the &#8220;Effective Date&#8221;), Catalyst Biosciences, Inc. (the &#8220;Company&#8221;) entered into an Agreement (the &#8220;Agreement&#8221;), with JDS1, LLC (&#8220;JDS1&#8221;), CCUR Holdings,
      Inc., CIDM II, LLC, Julian D. Singer, David S. Oros (collectively, the &#8220;Investor Group Parties&#8221;) and Karen S. Singer and Gary A. Singer (collectively, with the Investor Group Parties, the &#8220;Investors&#8221;). As of the date of the Agreement, the Investor
      Group Parties collectively beneficially owned an aggregate of 2,636,042 shares, or approximately 8.4%, of outstanding common stock. Under the Agreement, JDS1 dismissed with prejudice its lawsuits captioned JDS1, LLC v. Catalyst Biosciences, Inc.,
      C.A. No. 2022-0350-KSJM (Del. Ch.) and JDS1, LLC v. Catalyst Biosciences, Inc., et al., C.A. No. 2022-0515-KSJM (Del. Ch.) and, following dismissal of the lawsuits, the Company reimbursed JDS1 for its legal and other expenses related to the
      litigation and JDS1&#8217;s involvement with the Company in the amount of $400,000. In addition, the Investors agreed to customary standstill provisions while all parties agreed to customary representations and warranties, restrictions on bringing
      litigation against other parties during the standstill period, and a general release of claims.&#160; During the standstill period, each of the Investors also agreed to vote all of the Company&#8217;s shares beneficially owned by such Investor and its affiliate
      in favor of the election of any director nominee nominated by the Company&#8217;s Board of Directors.</div>

    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">A copy of the Agreement is included as Exhibit 99.1. The foregoing description of the Agreement is not purported to be complete and qualified in its entirety by reference
      to the full text of the Agreement, which is incorporated herein by reference.</div>

    <div style="font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 63pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">Financial Statements and Exhibits.</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(d)&#160; Exhibits</div>

    <div style="font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;"><span style="text-decoration: underline;">Exhibit No.</span></div>
          </td>

    <td style="width: 90%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;"><span style="text-decoration: underline;">Description</span></div>
          </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 10%; vertical-align: top; font-size: 10pt;"><br />
          </td>

    <td rowspan="1" style="width: 90%; vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; margin-right: 63pt; font-family: 'Times New Roman';"><a href="brhc10041057_ex99-1.htm">99.1</a></div>
          </td>

    <td style="width: 90%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; margin-right: 63pt; font-family: 'Times New Roman';">Agreement, effective as of August 18, 2022, between Catalyst Biosciences, Inc. and certain Investors specified therein.</div>
          </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 10%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td rowspan="1" style="width: 90%; vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; margin-right: 63pt; font-family: 'Times New Roman';">104</div>
          </td>

    <td style="width: 90%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; margin-right: 63pt; font-family: 'Times New Roman';">Cover Page Interactive Data File (formatted as Inline XBRL document).</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;"><br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURES</div>

    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
      authorized.</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> </span><span style="font-size: 10pt;"><br />
      </span></div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 50.45%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 49.55%; vertical-align: bottom; font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">CATALYST BIOSCIENCES, INC.</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50.45%; vertical-align: middle; font-size: 10pt;">&#160;</td>

    <td style="width: 49.55%; vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50.45%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Date: August 19, 2022</div>
          </td>

    <td style="width: 49.55%; vertical-align: bottom; border-bottom: 2px solid #000000;">
            <div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Nassim Usman</div>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 50.45%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 49.55%; vertical-align: bottom; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Nassim Usman, Ph.D.</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50.45%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 49.55%; vertical-align: bottom; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">President and Chief Executive Officer</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;"><br />
    </div>

    <div style="font-size: 10pt;"><br />
    </div>

    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

  </div>

  <div><span style="font-size: 10pt;"> </span></div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>brhc10041057_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 22.7.2.5062
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"><font style="font-weight: bold; font-size: 10pt;">Exhibit 99.1</font><font style="font-size: 10pt;"><br>
      </font> </div>
    <div style="text-align: left;"><font style="font-weight: bold; font-size: 10pt;"> </font><font style="font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: left;">
      <div style="text-align: right; font-weight: bold; font-size: 10pt;">&#160;EXECUTION VERSION </div>
      <div><font style="font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Cooperation Agreement</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 45pt;">This <font style="font-family: 'Times New Roman'; font-weight: bold;">Cooperation Agreement </font>(this &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Agreement</font>&#8221;) is made and entered into as of August 18, 2022 (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Effective Date</font>&#8221;) by and among
        Catalyst Biosciences, Inc., a Delaware corporation (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Company</font>&#8221;), and each of the parties listed on <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Exhibit A</u>&#160;</font>hereto (each, an &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Investor</font>&#8221; and collectively, the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Investors</font>&#8221; or, with their respective controlled Affiliates, except as noted on Exhibit A, the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Investor Group</font>&#8221;). The
        Company and each of the Investors are each herein referred to as a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">party</font>&#8221; and collectively, the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">parties</font>.&#8221;)</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 45pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Whereas</font><font style="font-size: 10pt;">, each of the
          Investors beneficially owns the number of shares of the Company&#8217;s common stock, par value $0.001 per share (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Common Stock</font>&#8221;) listed on <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Exhibit A</u>&#160;</font>hereto;</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 45pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Whereas</font><font style="font-size: 10pt;">, on April 20, 2022,
          JDS1, LLC, a Delaware limited liability company (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">JDS1</font>&#8221;), filed a lawsuit captioned <font style="font-family: 'Times New Roman'; font-style: italic;">JDS1,

            LLC v. Catalyst Biosciences, Inc.</font>, C.A. No. 2022-0350-KSJM (Del. Ch.) against the Company pursuant to Section 220 of the Delaware General Corporation Law (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">DGCL</font>&#8221;) (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Section 220 Litigation</font>&#8221;).</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 45pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Whereas</font><font style="font-size: 10pt;">, on June 15, 2022,
          JDS1 filed a lawsuit captioned <font style="font-family: 'Times New Roman'; font-style: italic;">JDS1, LLC v. Catalyst Biosciences, Inc., et al.</font>, C.A. No. 2022-0515-KSJM (Del. Ch.) against the Company and its Board of Directors (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Board</font>&#8221;) alleging, among other things, violations of Section 271 of the DGCL (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Section 271 Litigation</font>&#8221;).</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 45pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Whereas</font><font style="font-size: 10pt;">, the Company has
          reached an agreement with each of the Investors with respect to certain matters as provided in this Agreement.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 45pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Now, Therefore</font><font style="font-size: 10pt;">, in
          consideration of the premises and mutual covenants and agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Investors, on a several and not joint basis, and
          the Company hereby agree as follows:</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Section 1.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>JDS1 to Withdraw from Certain Legal Actions</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z5b353a41ac20468686a0ff6e04c47938">

          <tr>
            <td style="width: 16pt;"><font style="font-size: 10pt;"><br>
              </font> </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">a.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Dismissal with Prejudice of Section 271 Litigation</u>. </font><font style="font-size: 10pt;">JDS1

                  shall file a stipulation of dismissal of the Section 271 Litigation with prejudice substantially in the form attached as <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Exhibit B</u>&#160;</font>hereto no later than 12:00
                  p.m. EDT on the second Business Day following the Effective Date (the time of filing such stipulation hereinafter referred to as the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Section 271
                    Litigation Dismissal Time</font>&#8221;).</font></div>
            </td>
          </tr>

      </table>
      <div><font style="font-size: 10pt;"><br>
        </font> </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="zfc3be028052a422b9188de11876382b1">

          <tr>
            <td style="width: 16pt;"><font style="font-size: 10pt;"><br>
              </font> </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">b.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Dismissal with Prejudice of the Section 220 Litigation and Withdrawal of Section 220 Demand</u>.
                </font><font style="font-size: 10pt;">JDS1 shall file a stipulation of dismissal of the Section 220 Litigation with prejudice substantially in the form attached as <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Exhibit
                      C</u>&#160;</font>hereto no later than 12:00 p.m. EDT on the second Business Day following the Effective Date (the time of filing such stipulation hereinafter referred to as the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Section 220 Litigation Dismissal Time</font>&#8221;) and, effective at the Section 220 Litigation Dismissal Time, JDS1 shall be deemed to have irrevocably withdrawn the stockholder inspection demand letter (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Section 220 Demand</font>&#8221;) that it delivered to the Company on March 15, 2022, pursuant to Section 220 of the DGCL.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 2.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Voting Agreement</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">During the Standstill Period (defined in <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 4</u></font>) each of the Investors agrees to
        vote all shares of Common Stock beneficially owned by each Investor and its Affiliates (as defined below) in favor of the election of any director nominee nominated by the Board; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>,
        <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, nothing in this Agreement (including without limitation with respect to <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 4</u>&#160;</font>below)

        shall restrict an Investor from voting freely on any stockholder approval for any merger, material acquisition or disposition, or a liquidation and winding up of the Company that is submitted by the Company for stockholder approval.</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: left; margin-left: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 3.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Reimbursement of Fees and Expenses</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">On the same day that JDS1 fulfills its obligations under this Agreement under <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Sections 1(a) </u></font><font style="font-family: 'Times New Roman';"><u>and </u></font><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>1(b)</u>&#160;</font>above, and no later than two (2) hours following the later of (a) the Section 271 Litigation Dismissal
        Time, and (b) the Section 220 Litigation Dismissal Time (such deadline hereinafter referred to as the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Expense Reimbursement Payment Deadline</font>&#8221;), the Company
        shall pay to JDS1, via same-day wire transfer of immediately available funds, and following the wire transfer instructions communicated by JDS1, via e- mail or otherwise, to the Company&#8217;s Chief Executive Officer, Interim Chief Financial Officer, or
        the legal counsel referenced in <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 12</u>&#160;</font>hereof, the amount of $400,000 (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Expense

          Reimbursement Amount</font>&#8221;), as reimbursement for JDS1&#8217;s out-of-pocket fees and expenses (including legal expenses) incurred in connection with its involvement with the Company through the Effective Date, including, but not limited to its
        filings with the Securities and Exchange Commission (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">SEC</font>&#8221;), its notices and correspondence to the Company, its proxy contest against the Company, its
        stockholder inspection demand, the Section 271 Litigation and the Section 220 Litigation against the Company, its engagement with the Company&#8217;s Representatives, and the negotiation and execution of this Agreement. If the Expense Reimbursement
        Payment Deadline occurs after the cut-off time of the transferring financial institutions, the Company shall have until 11:00 a.m. EDT of the next Business Day following the day of the Expense Reimbursement Payment Deadline to transfer the Expense
        Reimbursement Amount without incurring the Late Payment Fees and Interests (defined below). For the avoidance of doubt, it is expressly understood that JDS1 shall not be required to provide the Company with any documentation with respect to its
        expenses incurred. The Company acknowledges that the Company&#8217;s agreement to pay JDS1 the Expense Reimbursement Amount by the Expense Reimbursement Payment Deadline is a key, material, bargained- for element to this Agreement without which JDS1
        would not have agreed, pursuant to the terms hereof, to withdraw the Section 271 Litigation, the Section 220 Litigation, and enter into this Agreement. If the Company does not make payment to JDS1 of the Expense Reimbursement Amount by the Expense
        Reimbursement Payment Deadline, JDS1 shall be entitled to all fees and expenses, including attorneys&#8217; fees and litigation and court costs that it incurs in connection with its efforts to collect the Expense Reimbursement Amount as well as interest
        accruing from and after the Expense Reimbursement Payment Deadline on the unpaid balance of the Expense Reimbursement Amount (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Late Payment Fees and Interests</font>&#8221;).

        Such interest shall accrue at a rate equal to the annualized Federal Funds Rate plus ten percent (10%) and shall be compounded daily.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 4.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Standstill</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Each Investor agrees that, for the period commencing immediately following the payment of the Expense Reimbursement Amount pursuant to <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 3</u>&#160;</font>(the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Releases Effectiveness Time</font>&#8221;) and ending on the earliest of (i) the one year
        anniversary of the Agreement, or (ii) a material breach by the Company of its obligations under this Agreement which is not cured within five (5) Business Days after written notice from any Investor (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Standstill Period</font>&#8221;), neither it nor any of its controlled Affiliates will, and it will cause each of its controlled Affiliates not to, directly or indirectly, acting alone or in concert with
        others:</div>
      <div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">submit any stockholder proposal
              (pursuant to Rule 14a-8 promulgated by the SEC under the Exchange Act or otherwise) or any notice of nomination or other business for consideration, or nominate any candidate for election to the Board (including by way of Rule 14a-11 of
              Regulation 14A), other than as expressly permitted by this Agreement;</font></font></div>
      </div>
      <font style="font-size: 10pt;"><br>
      </font>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">2</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">engage in, directly or indirectly,
            any &#8220;solicitation&#8221; (as defined in Rule 14a- 1 of Regulation 14A) of proxies (or written consents) or otherwise become a &#8220;participant in a solicitation&#8221;(as such term is defined in Instruction 3 of Schedule 14A of Regulation 14A under the
            Exchange Act) in opposition to the recommendation or proposal of the Board, or recommend or request or induce or attempt to induce any other person to take any such actions, or seek to advise, encourage or influence any other person with
            respect to the voting of the Common Stock (including any withholding from voting) or grant a proxy with respect to the voting of the Common Stock or other voting securities to any person other than to the Board or persons appointed as proxies
            by the Board;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">seek to call, or to request the
            call of, a special meeting of the Company&#8217;s stockholders, or make a request for a list of the Company&#8217;s stockholders or to inspect any books and records of the Company;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">form, join in or in any other way
            participate in a &#8220;partnership, limited partnership, syndicate or other group&#8221; within the meaning of Section 13(d)(3) of the Exchange Act with respect to the Common Stock or deposit any shares of Common Stock in a voting trust or similar
            arrangement or subject any shares of Common Stock to any voting agreement or pooling arrangement, other than a group consisting only of some or all of the Investors and their Affiliates;</font></font></div>
      <div style="text-indent: 63pt;">&#160;</div>
      <div style="text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v) &#160; &#160;&#160;&#160;&#160;&#160; &#160; vote for any nominee or nominees for election to the Board, other than those nominated or supported by the Board;</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(vi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">seek to place a Representative or
            other Affiliate or nominee on the Board or seek the removal of any member of the Board or a change in the size or composition of the Board;</font></font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(vii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">acquire or agree, offer, seek or
            propose to acquire, or cause to be acquired, ownership (including beneficial ownership) of any of the assets or business of the Company or any rights or options to acquire any such assets or business from any person, in each case other than
            securities of the Company;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(viii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">other than at the direction of the
            Board, seek, propose or make any statement (other than to one or more members of the Board or management or its advisors or agents) with respect to, or solicit, or negotiate with or provide any information to any person with respect to, a
            merger, consolidation, acquisition of control or other business combination, tender or exchange offer, purchase, sale or transfer of assets or securities, dissolution, liquidation, reorganization, change in structure or composition of the
            Board, change in the executive officers of the Company, change in capital structure, recapitalization, dividend, share repurchase or similar transaction involving the Company, its subsidiaries or its business, whether or not any such
            transaction involves a change of control of the Company (it being understood that the foregoing shall not restrict the Investors from tendering Common Stock, receiving payment for Common Stock or otherwise participating in any such transaction
            on the same basis as other stockholders of the Company, or from participating in any such transaction that has been approved by the Board);</font></font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
          </font></font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ix)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">acquire,
            announce an intention to acquire, offer or propose to acquire, or agree to acquire, directly or indirectly, by purchase or otherwise, beneficial ownership of (A) any interests in the Company&#8217;s indebtedness or (B) an aggregate amount of more
            than 9.99% of the Company&#8217;s outstanding Common Stock (which shall not include Common Stock issued in connection with a stock split, stock dividend or similar corporate action initiated by the Company with respect to any securities beneficially
            owned by any of the Investors or their Affiliates); <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>,
            nothing herein shall prevent any Investor from confidentially seeking a waiver from this provision;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(x)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">short sell the Company&#8217;s capital
            stock, or otherwise pledge, hypothecate or put any liens against the Company&#8217;s capital stock, except that an Investor may partake in customary margin transactions with a broker regulated by FINRA;</font></font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
          </font></font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">3</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">disclose publicly, or privately in a
            manner that could reasonably be expected to become public, any intention, plan or arrangement inconsistent with the foregoing;</font></font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> <br>
        </font></div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">take any action challenging the
            validity or enforceability of any provisions of this <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 4</u></font>; or</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xiii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">enter into any agreement,
            arrangement or understanding concerning any of the foregoing (other than this Agreement) or encourage or solicit any person to undertake any of the foregoing activities.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Except as expressly provided in <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 2</u></font>, each of the Investors shall be entitled to
        (i) vote any shares of Common Stock that it beneficially owns as it determines in its sole discretion, and (ii) disclose, publicly or otherwise, how it intends to vote or act with respect to any securities of the Company, any stockholder proposal
        or other matter to be voted on by the stockholders of the Company and the reasons therefor. This <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 4</u>&#160;</font>shall not restrict the ability of the Investors and each of
        their Affiliates and other Representatives to privately communicate with the Company and its Representatives so long as such private communications would not be reasonably expected to trigger public disclosure obligations for any party.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 5.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Representations and Warranties of the Company</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The Company represents and warrants to the Investors that (a) the Company has the corporate power and authority to execute this Agreement and to bind it thereto, (b)
        this Agreement has been duly and validly authorized, executed and delivered by the Company, constitutes a valid and binding obligation and agreement of the Company, and is enforceable against the Company in accordance with its terms, except as
        enforcement thereof may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance or similar laws generally affecting the rights of creditors and subject to general equity principles, (c) the execution,
        delivery and performance of this Agreement by the Company does not and will not (i) violate or conflict with any law, rule, regulation, order, judgment or decree applicable to it, or (ii) result in any breach or violation of or constitute a default
        (or an event which with notice or lapse of time or both could become a default) under or pursuant to, or result in the loss of a material benefit under, or give any right of termination, amendment, acceleration or cancellation of, any
        organizational document, or any material agreement, contract, commitment, understanding or arrangement to which the Company is a party or by which it is bound.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">&#160;&#160;&#160; Section 6.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Representations and Warranties of the Investors</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify;">Each Investor, on behalf of itself, severally and not jointly represents and warrants to the Company that (a) as of the Effective Date, such Investor beneficially owns only the number of shares of Common Stock as
        described opposite its name on <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Exhibit A</u></font>, and <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Exhibit A</u>&#160;</font>includes all Affiliates of any
        Investors that own any securities of the Company beneficially or of record, (b) this Agreement has been duly and validly authorized, executed and delivered by such Investor, and constitutes a valid and binding obligation and agreement of such
        Investor, enforceable against such Investor in accordance with its terms, except as enforcement thereof may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance or similar laws generally affecting the
        rights of creditors and subject to general equity principles, (c) such Investor has the authority to execute this Agreement on behalf of itself and the applicable Investor associated with that signatory&#8217;s name, and to bind such Investor to the
        terms hereof, and (d) the execution, delivery and performance of this Agreement by such Investor does not and will not<font style="font-size: 10pt; font-family: 'Times New Roman';"> (i)</font><font style="font-size: 10pt;">&#160; <font style="font-family: 'Times New Roman';">violate or conflict with any law, rule, regulation, order, judgment or decree applicable to it, or (ii) result in any breach or violation of or constitute a default (or an event which with notice or lapse
            of time or both could become a default) under or pursuant to, or result in the loss of a material benefit under, or give any right of termination, amendment, acceleration or cancellation of, any organizational document, agreement, contract,
            commitment, understanding or arrangement to which such member is a party or by which it is bound.</font></font></div>
      <div style="text-align: justify;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
          </font></font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">4</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: left; margin-left: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 7.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold; font-family: 'Times New Roman';"><u>No Litigation and General Release of Claims</u></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">From the Releases Effectiveness Time and until the end of the Standstill Period, each party hereby covenants and agrees that it shall not, and shall not permit any of
        its Affiliates or Representatives to, directly or indirectly, alone or in concert with others, encourage, pursue, or assist any other person to threaten or initiate any lawsuit, claim, or other proceeding before any court (each, a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Legal Proceeding</font>&#8221;) against the other party, any of its Affiliates, or its Representatives, except for (a) any Legal Proceeding initiated primarily to remedy a
        breach of or to enforce this Agreement, or (b) counterclaims with respect to any proceeding initiated by or on behalf of one party or its Affiliates against any other party or its Affiliates; <font style="font-family: 'Times New Roman'; font-style: italic;">provided, however</font>, that the foregoing shall not prevent any party or any of its Representatives from responding to oral questions, interrogatories, requests for information or documents, subpoenas, civil investigative
        demands or similar processes (each, a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Legal Requirement</font>&#8221;) in connection with any Legal Proceeding if such Legal Proceeding has not been initiated by, on
        behalf of, or at the direct or indirect suggestion of such party or any of its Representatives; provided, further, that in the event any party or any of its Representatives receives such Legal Requirement, such party shall give prompt written
        notice of such Legal Requirement to the other party (except where such notice would be legally prohibited or not practicable). Each party represents and warrants to each other party that neither it nor any assignee has filed any Legal Proceeding or
        is aware of any Legal Proceeding, or a Legal Requirement related thereto, against any other party that has not been disclosed to such other party prior to the date hereof. It is understood and that in consideration of the mutual promises and
        covenants contained herein, and after consultation with their respective counsel, the Company, on the one hand, and each other party, on the other hand, on behalf of themselves and for all of their past and present affiliated, associated, related,
        parent and subsidiary companies, joint venturers, limited liability companies, and partnerships, successors, assigns, and the respective owners, officers, directors, nominees for election to the Board, agents, employees, shareholders, members,
        consultants and attorneys, Affiliates, Immediate Family members, and other Representatives of each of them (collectively &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Affiliated Persons</font>&#8221;), irrevocably
        and unconditionally release, acquit and forever discharge the other and all of their Affiliated Persons, from any and all causes of action, claims, actions, rights, judgments, obligations, damages, demands, losses, controversies, contentions,
        complaints, promises, accountings, bonds, bills, debts, dues, sums of money, expenses, specialties and fees and costs (whether direct, indirect or consequential, incidental or otherwise including, without limitation, attorney&#8217;s fees or court costs,
        of whatever nature) incurred in connection therewith of any kind whatsoever, whether known or unknown, suspected or unsuspected, in their own right and derivatively, in law or in equity or liabilities of whatever kind or character (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Claims</font>&#8221;), which the parties have or may have against one another based upon events occurring prior to the date of the execution of this Agreement, including,
        without limitation, arising out of or related to the Section 271 Litigation, the Section 220 Litigation, the engagement and interactions between the Investors and the Company (either directly or through their respective Representatives), the
        parties&#8217; communications with other investors in the Company, and the proxy solicitations conducted by each of the Company and the Investor Group in connection with the Company&#8217;s 2022 Annual Meeting of Stockholders (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Released Matters</font>&#8221;). The parties acknowledge that this general release of claims includes, but is not limited to, any and all statutory and common law claims for, among other
        things, fraud and breach of fiduciary duty based upon events occurring prior to the Effective Date. The parties intend that the foregoing release be broad with respect to the Released Matters, provided, however, this release and waiver of Claims
        does not release any rights and duties under this Agreement and shall not include any actions or claims any party may have for breach of, or to enforce, the terms of this Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Each of the parties to this Agreement represents and warrants that it has not heretofore transferred or assigned, or purported to transfer or assign, to any person,
        firm, or corporation any claims, demands,obligations, losses, causes of action, damages, penalties, costs, expenses, attorneys&#8217; fees, liabilities, or indemnities herein released.</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">5</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The Company, on the one hand, and the Investors, on the other hand, on behalf of themselves and their Affiliated Persons, each acknowledge that as of the Effective
        Date, the parties may have claims against an Affiliated Person that a party does not know or suspect to exist in his, her or its favor, including, but not limited to claims that, had they been known, might have affected the decision to enter into
        this Agreement, or to provide the general release set forth in this <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 7</u></font>. In connection with any such claims, the parties agree that they intend to waive,
        relinquish, and release any and all provisions, rights, and benefits any state or territory of the United States or other jurisdiction that purports to limit the application of a release to unknown claims, or to facts unknown at the time this
        Agreement was entered into. Without limiting the foregoing, the parties expressly waive any right or protection under Section 1542 of the California Civil Code, which provides: A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR
        RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY. In connection with
        the foregoing waiver, the parties acknowledge that they, or any of them, may (including after the Effective Date) discover facts in addition to or different from those known or believed by them to be true with respect to the subject matter of this
        Agreement, but it is the intention of the parties to complete, fully, finally, and forever compromise, settle, release, discharge, and extinguish any and all claims that they may have against each other and their Affiliated Person, known or
        unknown, suspected or unsuspected, contingent or absolute, accrued or unaccrued, apparent or unapparent, that now exist or previously existed, without regard to the subsequent discovery of additional or different facts. The parties acknowledge that
        the foregoing waiver is a key, material, bargained-for element to this Agreement and the general release that is part of it. </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 8.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Public Announcements</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160; (i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">No later than two (2) Business Days
            following the Effective Date, the Company shall file a Current Report on Form 8-K with the SEC reporting the entry into this Agreement and appending or incorporating by reference this Agreement as an exhibit thereto. The Company shall provide
            the Investor Group and its counsel a reasonable opportunity to review and comment on the Form 8-K prior to such filing, which comments shall be considered in good faith;</font></font></div>
      <div style="text-indent: 63pt;">&#160;</div>
      <div style="text-indent: 54pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160; (i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">No later than two (2) Business Days following the
            Effective Date, the Investor Group shall file an amendment to its Schedule 13D with respect to the Company that has been filed with the SEC, reporting the entry into this Agreement, amending applicable items to conform to their obligations
            hereunder and appending or incorporating by reference this Agreement as an exhibit thereto. The Investor Group shall provide the Company and its counsel a reasonable opportunity to review and comment on the Schedule 13D prior to such filing,
            which comments shall be considered in good faith.</font></font> </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 9.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-weight: bold;"><font style="font-family: 'Times New Roman';"><u>No Concession or Admission of Liability</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">This Agreement is being entered into for the purpose of avoiding litigation, uncertainty, controversy and legal expense, constitutes a compromise and settlement
        entered into by each party hereto, and shall not in any event constitute, be construed or deemed a concession or admission of any liability or wrongdoing of any of the parties hereto.</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">6</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Section 10.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Specific Performance</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Each of the Investors, on the one hand, and the Company, on the other hand, acknowledges and agrees that irreparable injury to the other party hereto may occur in the
        event any of the provisions of this Agreement are not performed in accordance with their specific terms or are otherwise breached and that such injury would not be adequately compensable in monetary damages. It is accordingly agreed that the
        Investors or any Investor, on the one hand, and the Company, on the other hand (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Moving Party</font>&#8221;), shall each be entitled to seek specific enforcement of,
        and injunctive or other equitable relief to prevent any violation of, the terms hereof, and the other party hereto agrees to (i) waive any requirement under any applicable law for the Moving Party to post any bond, and (ii) not take any action,
        directly or indirectly, in opposition to the Moving Party seeking such relief on the grounds that any other remedy or relief is available at law or in equity. This specific performance remedy shall not be the exclusive remedy for any violation of
        this Agreement. Any action for specific performance brought pursuant to this <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Section 10</u>&#160;</font>shall be brought exclusively in a Delaware state court.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 11.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold; font-family: 'Times New Roman';"><u>Definitions</u></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">As used in this Agreement:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z437f97797898402a839531ff903b4c6c">

          <tr>
            <td style="width: 36pt;"><font style="font-size: 10pt;"><br>
              </font> </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">a.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">the term &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Affiliate</font>&#8221; shall have the meaning set forth in Rule 12b-2 promulgated by the
                SEC under the Exchange Act, and include Immediate Family;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z5b81f5a88b904004af1c7a59a15005ad">

          <tr>
            <td style="width: 36pt;"><font style="font-size: 10pt;"><br>
              </font> </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">b.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">the term &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Associate</font>&#8221; shall have the meaning set forth in Rule 12b-2 promulgated by the
                SEC under the Exchange Act;</div>
            </td>
          </tr>

      </table>
      <div> <font style="font-size: 10pt;"><br>
        </font></div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z194b9bd084dd4207b185309941f88a60">

          <tr>
            <td style="width: 36pt;"><font style="font-size: 10pt;"><br>
              </font> </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">c.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">the terms &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">beneficial owner</font>&#8221; and &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">beneficial ownership</font>&#8221; shall have the same meanings as set forth in Rule 13d-3 promulgated by the SEC under the Exchange Act;</div>
            </td>
          </tr>

      </table>
      <div> <font style="font-size: 10pt;"><br>
        </font></div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="za3757bded5b1470b8a94ba7e10d78ef9">

          <tr>
            <td style="width: 36pt;"><font style="font-size: 10pt;"><br>
              </font> </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">d.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">the term &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Business Day</font>&#8221; means any day that is not a Saturday, Sunday or other day on
                which commercial banks in the State of California are authorized or obligated to be closed by applicable law;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z555b70561fec4b08ace88b67edd261ac">

          <tr>
            <td style="width: 36pt;"><font style="font-size: 10pt;"><br>
              </font> </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">e.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">the term &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">change of control</font>&#8221; shall mean the sale of all or substantially all the assets
                of the Company; any merger, consolidation or acquisition of the Company with, by or into another corporation, entity or person; or any change in the ownership of more than 50% of the voting capital stock of the Company in one or more
                related transactions;</div>
            </td>
          </tr>

      </table>
      <div> <font style="font-size: 10pt;"><br>
        </font></div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="za9b8649634da414ea261bd1ae3b638b0">

          <tr>
            <td style="width: 36pt;"><font style="font-size: 10pt;"><br>
              </font> </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">f.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">the term &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Immediate Family</font>&#8221; shall mean a spouse, child, grandchild or other lineal
                descendant (including by adoption), father, mother, brother or sister;</div>
            </td>
          </tr>

      </table>
      <div> <font style="font-size: 10pt;"><br>
        </font></div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="zf52d62519e9c40aeb0d36f10d7bcc297">

          <tr>
            <td style="width: 36pt;"><font style="font-size: 10pt;"><br>
              </font> </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">g.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">the terms &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">group</font>,&#8221; &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">proxy</font>&#8221; and &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">solicitation</font>&#8221; (and any plurals thereof) have the meanings ascribed to such terms under the Exchange Act
                and the rules and regulations promulgated thereunder, provided, that the meaning of &#8220;solicitation&#8221; shall be without regard to the exclusions set forth in Rules 14a-1(l)(2)(iv) and 14a-2 under the Exchange Act;</div>
            </td>
          </tr>

      </table>
      <div> <font style="font-size: 10pt;"><br>
        </font></div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="zfe44365719454b368848dae439d70a39">

          <tr>
            <td style="width: 36pt;"><font style="font-size: 10pt;"><br>
              </font> </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">h.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">the terms &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">person</font>&#8221; or &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">persons</font>&#8221; shall mean any individual, corporation (including not-for-profit), general or limited partnership, limited liability company, joint venture, estate, trust, association, organization or other entity of
                any kind or nature;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="zc5e4b63e8b4f47ed8a232f6bff35ae79">

          <tr>
            <td style="width: 36pt;"><font style="font-size: 10pt;"><br>
              </font> </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">i.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">the term &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Representatives</font>&#8221; means (i) a person&#8217;s Affiliates and Associates and (ii) its
                and their respective directors, officers, director nominees, employees, partners, members, managers, consultants, legal or other advisors, agents and other representatives acting in a capacity on behalf of, in concert with or at the
                direction of such person or its Affiliates or Associates;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div><font style="font-size: 10pt;"><br>
        </font> </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">7</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z3c36238153ae44069b2bc633ffc3991f">

          <tr>
            <td style="width: 36pt;"><font style="font-size: 10pt;"><br>
              </font> </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">j.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">the term &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">third party</font>&#8221; refers to any person that is not a party, a member of the Board,
                a director or officer of the Company, or legal counsel to either party.</div>
            </td>
          </tr>

      </table>
      <div> <font style="font-size: 10pt;"><br>
        </font></div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z2c6ee93be1f54e82b39688eee76d781f">

          <tr>
            <td style="width: 36pt;"><font style="font-size: 10pt;"><br>
              </font> </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">k.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">In this Agreement, unless a clear contrary intention appears, (i) the word &#8220;including&#8221; (in its various forms) means &#8220;including, without limitation;&#8221; (ii) the words &#8220;hereunder,&#8221;
                &#8220;hereof,&#8221; &#8220;hereto&#8221; and words of similar import are references in this Agreement as a whole and not to any particular provision of this Agreement; (iii) the word &#8220;or&#8221; is not exclusive; (iv) references to &#8220;Sections&#8221; in this Agreement are
                references to Sections of this Agreement unless otherwise indicated; and (v) whenever the context requires, the masculine gender shall include the feminine and neuter genders.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 12.&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Notice</u></font><font style="font-size: 10pt;">.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Any notices, consents, determinations, waivers or other communications required or permitted to be given under the terms of this Agreement must be in writing and will
        be deemed to have been delivered: (i) upon receipt, when delivered personally; or (ii) one (1) Business Day after deposit with a nationally recognized overnight delivery service and concurrently sent by e-mail, in each case properly addressed to
        the party to receive the same. The addresses and e-mail addresses for such communications shall be:</div>
      <div><font style="font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><u>To the Company:</u></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 63pt;">Catalyst Biosciences, Inc. </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 63pt;">Attention: Nassim Usman, Ph.D. </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 63pt;">611 Gateway Blvd., Suite 710</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 63pt;"> South San Francisco, CA 94080 </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 63pt;">Telephone: (650) 871-0761</div>
      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 63pt;"><u>E-mail: nusman@catbio.com</u></div>
      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 63pt;">with a copy to (which shall not constitute notice): </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 63pt;">Orrick, Herrington &amp; Sutcliffe LLP</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 63pt;">Attention: Stephen Thau </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 63pt;">51 W 52<font style="font-family: 'Times New Roman';">nd </font>St</div>
      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 63pt;">New York, NY 10019 </div>
      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 63pt;">Telephone: (212) 506-5076 </div>
      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 63pt;"><u><font style="font-family: 'Times New Roman';">E-mail: sthau@orrick.com</font></u></div>
      <div style="font-size: 10pt; margin-left: 63pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>To the Investors</u></font><font style="font-size: 10pt;">: As set forth in the respective addresses
          listed in <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Exhibit A</u>&#160;</font>hereto. For those Investors who are members of the Investor Group, a copy shall also be sent to (which shall not constitute notice):</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 63pt;">Gottfried Legal Advisory PLLC </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 63pt;">Attention: Keith E. Gottfried </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 63pt;">655 15th Street NW, Suite 800</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 63pt;">Washington, DC 20005-5705</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 63pt;">Telephone: (202) 627-0256</div>
      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 63pt;">E-mail: <font style="font-family: 'Times New Roman';"><u>Keith.Gottfried@gottfriedadvisory.com</u></font>.</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 63pt;">and</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 63pt;">Hunton Andrews Kurth LLP</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 63pt;"> Attention: Ryan P. Phair</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 63pt;">2200 Pennsylvania Avenue NW </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 63pt;">Washington, DC 20037</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 63pt;">Telephone (202) 955-1921</div>
      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 63pt;"><u>E-mail <font style="font-family: 'Times New Roman';">rphair@HuntonAK.com</font></u></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">8</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: left; margin-left: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 13.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Governing Law</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">This Agreement shall be governed by, and construed in accordance with, the law of the State of Delaware, without regard to conflict of law principles thereof, and each
        party irrevocably submits to the personal jurisdiction of the Chancery Court of Delaware as the exclusive venue for adjudication of any dispute hereunder.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 14.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Entire Agreement</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">This Agreement, together with the Exhibits hereto, constitutes the full and entire understanding and agreement among the parties with regard to the subject matter
        hereof, and supersedes all prior agreements and understandings, whether written or oral, with respect to the subject matter hereof. The Company may enter into a materially similar agreement with one or more other investors but any such agreement
        shall constitute a separate obligation and one investor shall not become a third party beneficiary of another investor&#8217;s agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 15.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold; font-family: 'Times New Roman';"><u>Receipt of Adequate Information; No Reliance; Representation by Counsel</u></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Each party acknowledges that it has received adequate information to enter into this Agreement, that it has not relied on any promise, representation or warranty,
        express or implied not contained in this Agreement and that it has been represented by counsel in connection with this Agreement. Accordingly, any rule of law or any legal decision that would provide any party with a defense to the enforcement of
        the terms of this Agreement against such party shall have no application and is expressly waived. The provisions of this Agreement shall be interpreted in a reasonable manner to effect the intent of the parties.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 16.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Severability</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">If any provision of this Agreement is held invalid or unenforceable by any court of competent jurisdiction, the other provisions of this Agreement shall remain in full
        force and effect. Any provision of this Agreement held invalid or unenforceable only in part or degree shall remain in full force and effect to the extent not held invalid or unenforceable. The parties further agree to replace such invalid or
        unenforceable provision of this Agreement with a valid and enforceable provision that will achieve, to the extent possible, the purposes of such invalid or unenforceable provision.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 17.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Amendment</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">This Agreement may be modified, amended or otherwise changed only in a writing signed by all of the parties, or, in the case of a writing required to be signed by the
        Investors, the Investor Representative.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 18.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Termination</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">This Agreement shall terminate at the end of the Standstill Period or other date established by mutual written agreement of the parties hereto. Notwithstanding the
        foregoing, the provisions of <font style="font-family: 'Times New Roman'; font-weight: bold;">Sections 7 </font>and <font style="font-family: 'Times New Roman'; font-weight: bold;">9 </font>thru <font style="font-family: 'Times New Roman'; font-weight: bold;">Section 22 </font>shall survive the termination of this Agreement. No termination of this Agreement shall relieve any party from liability for any breach of this Agreement prior to such termination.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section. 19</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Successors and Assigns; No Third Party Beneficiaries</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">This Agreement shall bind the successors and permitted assigns of the parties, and inure to the benefit of any successor or permitted assign of any of the parties; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that no party may assign this Agreement without the prior written consent of the other
        parties. No provision of this Agreement is intended to confer any rights, benefits, remedies, obligations or liabilities hereunder upon any person other than the parties hereto and the persons and entities released pursuant to Section 7 and their
        respective successors and assigns.</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <font style="font-size: 10pt;"><br>
        </font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">9</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: left; margin-left: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 20.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Counterparts</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">This Agreement may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon
        the same instrument. This Agreement shall become effective when each party hereto shall have received a counterpart hereof signed by the other parties hereto. Counterparts delivered by electronic transmission shall be deemed to be originally signed
        counterparts.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 21.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Several and Not Joint Liability</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">For the avoidance of doubt, the Investors are entering into this Agreement on a several, and not joint, basis. Any liability arising hereunder with respect to a
        specific Investor shall only apply to such specific Investor and shall not be shared among any other Investor a party hereto.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Section 22.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Investor Representative</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Each Investor hereby irrevocably appoints Julian D. Singer as its attorney-in-fact and representative (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Investor Representative</font>&#8221;), in such Investor&#8217;s place and stead, to do any and all things and to execute any and all documents and give and receive any and all notices or instructions in connection with this
        Agreement and the transactions contemplated hereby. The Company shall be entitled to rely, as being binding on each Investor, upon any action taken by the Investor Representative or upon any document, notice, instruction, or other writing given or
        executed by the Investor Representative.</div>
      <div><font style="font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(<font style="font-family: 'Times New Roman'; font-style: italic;">Signature page follows</font>)</div>
      <div><font style="font-size: 10pt;"><br>
        </font> </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">10</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">In Witness Whereof</font><font style="font-size: 10pt;">, the parties hereto have duly
          executed and delivered this Agreement as of the date first above written.</font></div>
      <div style="text-align: left; font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="zef6509a754504b00b694e2189e349cf9">

          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="vertical-align: top;" colspan="3" rowspan="1">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Catalyst Biosciences, Inc.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;" colspan="1">By: </td>
            <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Nassim Usman<br>
              </div>
            </td>
            <td style="width: 25%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" colspan="1">Name: </td>
            <td style="vertical-align: top;" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Nassim Usman, Ph.D.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" colspan="1">Title:</td>
            <td style="vertical-align: top;" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;President and Chief Executive Officer</div>
            </td>
          </tr>

      </table>
      <div> <font style="font-size: 10pt;"><br>
        </font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="946509e4f9bd407594832885a85daa0b">

            <tr>
              <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
              </td>
              <td style="vertical-align: top; font-size: 10pt;" rowspan="1" colspan="3"><font style="font-weight: bold;">JDS1 , LLC</font><br>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
              <td style="vertical-align: top; font-size: 10pt;" rowspan="1" colspan="3">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
              <td style="width: 5%; vertical-align: bottom; font-size: 10pt; padding-bottom: 2px; text-align: left;" colspan="1">
                <div>By: </div>
              </td>
              <td style="width: 25%; vertical-align: bottom; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0); text-align: left;">
                <div>/s/ Julian D.Singer</div>
              </td>
              <td style="width: 25%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
              <td style="width: 5%; vertical-align: bottom; font-size: 10pt; text-align: left;" colspan="1">Name:</td>
              <td style="vertical-align: bottom; font-size: 10pt; text-align: left;" colspan="2">&#160;Julian D. Singer </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
              <td style="width: 5%; vertical-align: bottom; font-size: 10pt; text-align: left;" colspan="1">Title: </td>
              <td style="vertical-align: bottom; font-size: 10pt; text-align: left;" colspan="2">&#160;Managing Member</td>
            </tr>

        </table>
        <div> <br>
        </div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;" id="z1aa6a606b02241739c18cc7a04e3ec48">

            <tr>
              <td style="width: 50%; font-size: 10pt;">
                <div>&#160;</div>
              </td>
              <td style="font-size: 10pt;" colspan="2" rowspan="1">
                <div style="font-weight: bold;">CCUR Holdings, Inc.</div>
              </td>
              <td style="width: 25%; font-size: 10pt;" colspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; font-size: 10pt;" rowspan="1">&#160;</td>
              <td style="width: 5%;" rowspan="1" colspan="1">&#160;</td>
              <td style="width: 25%;" rowspan="1">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><br>
                </div>
              </td>
              <td style="width: 25%;" rowspan="1" colspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; font-size: 10pt; padding-bottom: 2px;" rowspan="1">&#160;</td>
              <td style="width: 5%; text-align: left; vertical-align: bottom; padding-bottom: 2px;" rowspan="1" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">By:</div>
              </td>
              <td style="width: 25%; text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Igor Volshteyn</div>
              </td>
              <td style="width: 25%; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; font-size: 10pt;" rowspan="1">&#160;</td>
              <td style="width: 5%; text-align: left; vertical-align: bottom;" rowspan="1" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Name:</div>
              </td>
              <td style="width: 25%; text-align: left; vertical-align: bottom;" rowspan="1">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Igor Volshteyn</div>
              </td>
              <td style="width: 25%;" rowspan="1" colspan="1">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; font-size: 10pt;" rowspan="1">&#160;</td>
              <td style="width: 5%; font-size: 10pt; text-align: left; vertical-align: bottom;" rowspan="1" colspan="1"><font style="font-family: 'Times New Roman'; color: rgb(35, 35, 35);">Title</font><font style="font-family: 'Times New Roman'; color: rgb(68, 68, 68);">:</font></td>
              <td style="width: 25%; font-size: 10pt;" rowspan="1" colspan="2"><font style="font-family: 'Times New Roman'; color: rgb(35, 35, 35);">Chief Executive Officer and
                  President</font>&#160;</td>
            </tr>

        </table>
      </div>
      <div><font style="font-size: 10pt;"><br>
        </font> </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;" id="zf9acfedbf8794082919d3479933b6f31">

            <tr>
              <td style="width: 50%; font-size: 10pt;" colspan="1">&#160;</td>
              <td style="font-size: 10pt;" rowspan="1" colspan="3">
                <div style="font-weight: bold;">CIDM II, LLC</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; font-size: 10pt;" colspan="1" rowspan="1">&#160;</td>
              <td style="font-size: 10pt;" rowspan="1" colspan="3">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; padding-bottom: 2px; font-size: 10pt;" colspan="1">&#160;</td>
              <td style="width: 5%; padding-bottom: 2px; font-size: 10pt;">
                <div>By: </div>
              </td>
              <td style="width: 25%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
                <div>/s/Julian D.Singer</div>
              </td>
              <td style="width: 25%; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; font-size: 10pt;" rowspan="1" colspan="1">&#160;</td>
              <td style="width: 5%; font-size: 10pt;" rowspan="1">Name: </td>
              <td style="font-size: 10pt;" rowspan="1" colspan="2">Julian D. Singer </td>
            </tr>
            <tr>
              <td style="width: 50%; font-size: 10pt;" rowspan="1" colspan="1">&#160;</td>
              <td style="width: 5%; font-size: 10pt;" rowspan="1">Title: </td>
              <td style="font-size: 10pt;" rowspan="1" colspan="2">Managing Member</td>
            </tr>

        </table>
      </div>
      <div><font style="font-size: 10pt;"><br>
        </font> </div>
      <font style="font-size: 10pt;"> </font>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;" id="472017c54e474f1b860d4738fecdc912">

          <tr>
            <td style="width: 50%; padding-bottom: 2px; font-size: 10pt;" colspan="1" rowspan="1">&#160;</td>
            <td style="width: 50%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">/s/ Julian D. Singer <br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; font-size: 10pt;" colspan="1"><br>
            </td>
            <td style="width: 50%; font-size: 10pt; font-weight: bold;" rowspan="1">Julian D. Singer&#160;</td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: right; color: rgb(17, 17, 17); font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: left;">
          <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">

              <tr>
                <td style="width: 50%; padding-bottom: 2px; font-size: 10pt;" colspan="1" rowspan="1">&#160;</td>
                <td style="width: 50%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">/s/ David S. Oros</div>
                </td>
              </tr>
              <tr>
                <td style="width: 50%; font-size: 10pt;" colspan="1" rowspan="1">&#160;</td>
                <td style="width: 50%; font-size: 10pt;" rowspan="1">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">David S. Oros</div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
        </div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;" id="58e045cbfcab4b228997886eac14c153">

          <tr>
            <td style="width: 50%; padding-bottom: 2px; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 50%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">/s/ Karen S. Singer</td>
          </tr>
          <tr>
            <td style="width: 50%; font-size: 10pt;" rowspan="1" colspan="1">&#160;</td>
            <td style="width: 50%; font-size: 10pt; font-weight: bold;" rowspan="1">Karen S. Singer</td>
          </tr>

      </table>
      <div> <font style="font-size: 10pt;"><br>
        </font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;" id="0633c9993d414c0d9653ba5c6c30a5ce">

          <tr>
            <td style="width: 50%; padding-bottom: 2px; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 50%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" rowspan="1">
              <div style="text-align: left; margin-left: 1.4pt; font-family: 'Times New Roman'; font-weight: normal;">/s/ Gary A. Singer</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; font-size: 10pt;" rowspan="1" colspan="1">&#160;</td>
            <td style="width: 50%; font-size: 10pt;" rowspan="1">
              <div style="text-align: left; margin-left: 1.4pt; font-family: 'Times New Roman'; font-weight: bold;">Gary A. Singer</div>
            </td>
          </tr>

      </table>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u> <br>
        </u></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>Exhibit A</u></div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z4c158326f4dc49e58f9c6638de8a86ae">

          <tr>
            <td colspan="3" style="vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Investor Group Parties</div>
            </td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>Investor</u></div>
            </td>
            <td style="width: 34%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Shares of Common Stock</u></font><font style="font-size: 10pt;">&#160;<font style="font-family: 'Times New Roman';"><u></u></font></font></div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"><u>Beneficially Owned</u></font></font></div>
            </td>
            <td style="width: 33%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>Notice</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">JDS1, LLC</div>
            </td>
            <td style="width: 34%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">2,247,442 shares</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> (including (i) 1,131,577 shares</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">held directly (including 500 shares</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> held of record), and (ii) 1,115,865</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> shares held as an affiliate of CCUR Holdings)</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
              </div>
            </td>
            <td style="width: 33%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">2200 Fletcher Avenue, Suite 501 </div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Fort Lee, New Jersey 07024 </div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Telephone: 201-592-3400</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><u>E-mail: julian@remusllc.com</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">CCUR Holdings, Inc.</div>
            </td>
            <td style="width: 34%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">1,115,865 shares </div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(shares held directly)</div>
            </td>
            <td style="width: 33%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">3800 N Lamar Boulevard, Suite 200</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Austin, Texas 78756</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Telephone: 770-892-6424</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> E-mail:</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><u>Igor.Volshteyn@ccurholdings.com</u></div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><u> <br>
                </u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">CIDM II, LLC</div>
            </td>
            <td style="width: 34%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">1,115,865 shares</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(no shares held directly; shares </div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">beneficially held as Asset Manager</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> to CCUR Holdings, Inc.)</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
              </div>
            </td>
            <td style="width: 33%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">2200 Fletcher Avenue, Suite 501 </div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Fort Lee, New Jersey 07024 </div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Telephone: 201-592-3400</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><u>E-mail: julian@remusllc.com</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Julian D. Singer</div>
            </td>
            <td style="width: 34%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">2,247,442 shares</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(no shares held directly; shares</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> beneficially held as the sole</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> member of each of JDS1, LLC</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> and CIDM II, LLC)</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
              </div>
            </td>
            <td style="width: 33%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">2200 Fletcher Avenue, Suite 501</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> Fort Lee, New Jersey 07024</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> Telephone: 201-592-3400</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><u>E-mail: julian@remusllc.com</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">David S. Oros</div>
            </td>
            <td style="width: 34%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">388,600 shares</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> (shares held directly)</div>
            </td>
            <td style="width: 33%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">702 W. Lake Avenue</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> Baltimore, Maryland 21210</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Telephone: 443-386-0300</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><u>E-mail: doros@gamma3ll.com</u></div>
            </td>
          </tr>

      </table>
      <div> <font style="font-size: 10pt;"><br>
        </font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="zaad8d00c524844b387e46128772cd99b">

          <tr>
            <td colspan="3" style="vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Non-Investor Group Parties</div>
            </td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>Investor</u></div>
            </td>
            <td style="width: 34%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Shares of Common Stock</u></font><font style="font-size: 10pt;">&#160;<font style="font-family: 'Times New Roman';"><u></u></font></font></div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"><u>Beneficially Owned</u></font></font></div>
            </td>
            <td style="width: 33%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>Notice</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Karen S. Singer</div>
            </td>
            <td style="width: 34%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">0 shares</div>
            </td>
            <td style="width: 33%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">212 Vaccaro Drive, Cresskill, NJ</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> 07626</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Attention: Karen S. Singer</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> Telephone: 201-750-0415</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><u> Email: <font style="font-family: 'Times New Roman';">gary@pure1.com</font></u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Gary A. Singer</div>
            </td>
            <td style="width: 34%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">0 shares</div>
            </td>
            <td style="width: 33%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">212 Vaccaro Drive, Cresskill, NJ </div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">07626</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Attention: Gary A. Singer </div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Telephone: 201-750-0415 <u><br>
                  Email: <font style="font-family: 'Times New Roman';">gary@pure1.com</font></u></div>
            </td>
          </tr>

      </table>
      <div><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup><br>
      </div>
      <div><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"> <br>
        </sup></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit B</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Form of Stipulation of Dismissal with Prejudice</div>
      <div><font style="font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="zc470e708d5284401935b2bee37f9760d">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">JDS1, LLC,</div>
              <div style="font-size: 10pt; text-align: center;">&#160;</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Plaintiff,</div>
              <div style="font-size: 10pt;">&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt;">v.</div>
              <div style="font-size: 10pt;">&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">CATALYST BIOSCIENCES, INC., AUGUSTINE </div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">LAWLOR, ERROL B. DE SOUZA, ANDREA HUNT, </div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">JEANNE JEW, GEOFFREY LING, SHARON </div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">TETLOW, NASSIM USMAN, AND EDDIE </div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">WILLIAMS,</div>
              <div style="font-size: 10pt;">&#160;</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Defendants.</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div style="font-size: 10pt;">&#160;</div>
              <div style="font-size: 10pt;">&#160;</div>
              <div style="font-size: 10pt;">&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">C.A. No. 2022-0515-KSJM</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">STIPULATION OF</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <font style="font-family: 'Times New Roman';"><u>DISMISSAL WITH PREJUDICE</u></font></div>
      <div><font style="font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 99pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">IT IS HEREBY STIPULATED </font><font style="font-size: 10pt;">by
          the parties to this action, by and through their undersigned counsel, , pursuant to Court of Chancery Rule 41(a)(1)(ii), that this action is hereby voluntarily dismissed with prejudice. Each party shall bear its own costs.</font></div>
      <div><font style="font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[Signatures on following page.]</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div> <br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); width: 100%;" id="z8b90a0b903b24f0db6ed45a6dc2cdf5b">

            <tr>
              <td style="width: 33.33%;" colspan="2">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">ASHBY &amp; GEDDES</div>
              </td>
              <td style="width: 17%;"><br>
              </td>
              <td colspan="2">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">POTTER ANDERSON &amp; </div>
              </td>
            </tr>
            <tr>
              <td style="width: 33.33%;" colspan="2"><br>
              </td>
              <td style="width: 17%;"><br>
              </td>
              <td colspan="2">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">CORROON LLP</div>
              </td>
            </tr>
            <tr>
              <td style="width: 16.66%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">/s/ DRAFT</font><font style="font-size: 10pt;">&#160; <br>
                  </font></div>
              </td>
              <td style="width: 16.66%; padding-bottom: 2px;">&#160;</td>
              <td style="width: 17%; padding-bottom: 2px;"><br>
              </td>
              <td style="padding-bottom: 2px;" colspan="2">
                <div style="text-align: left;"><font style="font-size: 10pt;"><br>
                  </font></div>
              </td>
            </tr>
            <tr>
              <td style="width: 33.33%; padding-bottom: 2px;" colspan="2">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Catherine A. Gaul (#4310) </div>
              </td>
              <td style="width: 17%; padding-bottom: 2px;"><br>
              </td>
              <td style="width: 20%; border-bottom: 2px solid rgb(0, 0, 0);"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">/s/ DRAFT</font><font style="font-size: 10pt;"> </font></td>
              <td style="width: 30%; padding-bottom: 2px;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 33.33%;" colspan="2">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Michael J. Vail (#6994)</div>
              </td>
              <td style="width: 17%;"><br>
              </td>
              <td colspan="2">
                <div style="text-align: left;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';">Matthew F. Davis (#4696) </font></font></div>
              </td>
            </tr>
            <tr>
              <td style="width: 33.33%;" colspan="2">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">500 Delaware Avenue, 8th Floor</div>
              </td>
              <td style="width: 17%;"><br>
              </td>
              <td colspan="2"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';">Mathew A. Golden (#6035) </font></font></td>
            </tr>
            <tr>
              <td style="width: 33.33%;" colspan="2">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">P.O. Box 1150 </div>
              </td>
              <td style="width: 17%;"><br>
              </td>
              <td colspan="2"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';">Hercules Plaza &#8211; Sixth Floor</font></font></td>
            </tr>
            <tr>
              <td style="width: 33.33%;" colspan="2">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Wilmington, DE 19899</div>
              </td>
              <td style="width: 17%;"><br>
              </td>
              <td colspan="2">
                <div style="text-align: left;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';">1313 North Market Street </font></font></div>
              </td>
            </tr>
            <tr>
              <td style="width: 33.33%;" colspan="2">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(302) 654-1888</div>
              </td>
              <td style="width: 17%;"><br>
              </td>
              <td colspan="2">
                <div style="text-align: left;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';">Wilmington, Delaware 19801</font></font></div>
              </td>
            </tr>
            <tr>
              <td style="width: 33.33%;" rowspan="1" colspan="2"><br>
              </td>
              <td style="width: 17%;" rowspan="1"><br>
              </td>
              <td rowspan="1" colspan="2">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(302) 984-6000</div>
              </td>
            </tr>

        </table>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="zf8c0364ebebf4ea7a4b82815fe6d82e5">

          <tr>
            <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Of Counsel</font><font style="font-size: 10pt;">:</font></div>
              <div style="font-size: 10pt;">&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">HUNTON ANDREWS </div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">KURTH LLP</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Ryan P. Phair</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">2200 Pennsylvania Avenue, NW </div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Washington, DC 20037</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(202) 955-1921</div>
              <div style="font-size: 10pt;">&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Laura T. Wagner</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Bank of America Plaza, Suite 4100</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> 600 Peachtree Street, NE</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Atlanta, Georgia 30308</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(404) 888-4000</div>
              <div style="font-size: 10pt;">&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Attorneys for Plaintiff JDS1, LLC</div>
            </td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Attorneys for Defendants Catalyst Biosciences, Inc.,</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"> Augustine Lawlor, Errol B. de Souza, Andrea Hunt, </div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Jeanne Jew, Geoffrey Ling, Sharon Tetlow, Nassim</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"> Usman, and Eddie Williams</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;Dated: August<font style="font-family: 'Times New Roman';"><u>&#160;</u></font>, 2022</td>
            <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>

      </table>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit C</div>
      <div><font style="font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Form of Stipulation of Dismissal with Prejudice</div>
      <div><font style="font-size: 10pt;"><br>
        </font> </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE</div>
      <div><font style="font-size: 10pt;"><br>
        </font> </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="za001979b678d4ef28f72f198a1c015aa">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">JDS1, LLC,</div>
              <div style="font-size: 10pt;">&#160;</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Plaintiff,</div>
              <div style="font-size: 10pt;">&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 45pt;">v.</div>
              <div style="font-size: 10pt;">&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">CATALYST BIOSCIENCES, INC.,</div>
              <div style="font-size: 10pt;">&#160;</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Defendants.</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>
            <td style="width: 45%; vertical-align: top;">
              <div style="font-size: 10pt;">&#160;</div>
              <div style="font-size: 10pt;">&#160;</div>
              <div style="font-size: 10pt;">&#160;</div>
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">C.A. No. 2022-0350-KSJM</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">STIPULATION OF <font style="font-family: 'Times New Roman';"><u></u></font></div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font style="font-family: 'Times New Roman';"><u>DISMISSAL WITH PREJUDICE</u></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">IT IS HEREBY STIPULATED </font><font style="font-size: 10pt;">by
          the parties to this action, by and through their undersigned counsel, pursuant to Court of Chancery Rule 41(a)(1)(ii), that this action is hereby voluntarily dismissed with prejudice. Each party shall bear its own costs.</font></div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 108pt;"><font style="font-size: 10pt;"> <br>
        </font></div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[Signatures on following page.]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); width: 100%;" id="5eb316fa7aed4a74b6d0da0a4fd2545d">

          <tr>
            <td style="width: 48%;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">DAILEY LLP</div>
            </td>
            <td style="width: 4%;" colspan="1">&#160;</td>
            <td style="width: 48%;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">ABRAMS &amp; BAYLISS LLP</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%;">&#160;</td>
            <td style="width: 4%;" colspan="1">&#160;</td>
            <td style="width: 48%;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 48%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">/s/ DRAFT</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br>
                </font></div>
            </td>
            <td style="width: 4%; padding-bottom: 2px;" colspan="1">&#160;</td>
            <td style="width: 48%; border-bottom: 2px solid rgb(0, 0, 0);">&#160; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">/s/ DRAFT</font><font style="font-size: 10pt;"> <br>
              </font></td>
          </tr>
          <tr>
            <td style="width: 48%;" rowspan="1">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Andrew H. Sauder (#5560)</div>
            </td>
            <td style="width: 4%;" colspan="1" rowspan="1">&#160;</td>
            <td style="width: 48%;" rowspan="1">&#160;A. Thompson Bayliss (#4310) <br>
            </td>
          </tr>
          <tr>
            <td style="width: 48%;" rowspan="1">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">1201 N. Orange Street, Suite 7300</div>
            </td>
            <td style="width: 4%;" colspan="1" rowspan="1">&#160;</td>
            <td style="width: 48%;" rowspan="1">&#160;Adam K. Schulman (#5700)</td>
          </tr>
          <tr>
            <td style="width: 48%;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Wilmington, Delaware 19801</div>
            </td>
            <td style="width: 4%;" colspan="1">&#160;</td>
            <td style="width: 48%;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">20 Montchanin Road, Suite 200</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(302) 415-3560</div>
            </td>
            <td style="width: 4%;" colspan="1">&#160;</td>
            <td style="width: 48%;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Wilmington, Delaware 19807</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%;"><br>
            </td>
            <td style="width: 4%;" colspan="1">&#160;</td>
            <td style="width: 48%;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(302) 778-1000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%;" rowspan="1">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Attorneys for Plaintiff JDS1, LLC</div>
            </td>
            <td style="width: 4%;" rowspan="1" colspan="1">&#160;</td>
            <td style="width: 48%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 48%;"><br>
            </td>
            <td style="width: 4%;" colspan="1">&#160;</td>
            <td style="width: 48%;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%;" rowspan="1">&#160;</td>
            <td style="width: 4%;" rowspan="1" colspan="1">&#160;</td>
            <td style="width: 48%;" rowspan="1">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Of Counsel</font><font style="font-size: 10pt;">:</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%;" rowspan="1">&#160;</td>
            <td style="width: 4%;" rowspan="1" colspan="1">&#160;</td>
            <td style="width: 48%;" rowspan="1">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">ORRICK, HERRINGTON &amp; SUTCLIFFE LLP</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%;" rowspan="1">&#160;</td>
            <td style="width: 4%;" rowspan="1" colspan="1">&#160;</td>
            <td style="width: 48%;" rowspan="1">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Alexander K. Talarides 405 Howard Street</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%;" rowspan="1">&#160;</td>
            <td style="width: 4%;" rowspan="1" colspan="1">&#160;</td>
            <td style="width: 48%;" rowspan="1">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">San Francisco, California 94105 (415) 773-5700</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%;" rowspan="1">&#160;</td>
            <td style="width: 4%;" rowspan="1" colspan="1">&#160;</td>
            <td style="width: 48%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 48%;" rowspan="1">&#160;</td>
            <td style="width: 4%;" rowspan="1" colspan="1">&#160;</td>
            <td style="width: 48%;" rowspan="1">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Stephen Thau</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%;" rowspan="1">&#160;</td>
            <td style="width: 4%;" rowspan="1" colspan="1">&#160;</td>
            <td style="width: 48%;" rowspan="1">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">51 West 52nd Street</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%;" rowspan="1">&#160;</td>
            <td style="width: 4%;" rowspan="1" colspan="1">&#160;</td>
            <td style="width: 48%;" rowspan="1">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">New York, New York 10019 (212) 506-5000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%;" rowspan="1">&#160;</td>
            <td style="width: 4%;" rowspan="1" colspan="1">&#160;</td>
            <td style="width: 48%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 48%;" rowspan="1">&#160;</td>
            <td style="width: 4%;" rowspan="1" colspan="1">&#160;</td>
            <td style="width: 48%;" rowspan="1">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Attorneys for Defendant Catalyst Biosciences, Inc.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48%;" rowspan="1">&#160;Dated: August<font style="font-family: 'Times New Roman';"><u>&#160;</u></font>, 2022</td>
            <td style="width: 4%;" rowspan="1" colspan="1">&#160;</td>
            <td style="width: 48%;" rowspan="1">&#160;</td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160;
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <hr noshade="noshade" align="center" style="height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); text-align: center; margin-left: auto; margin-right: auto; border: medium none;"></div>
    </div>
  </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cbio-20220818.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.7.2.5062 Broadridge-->
<xs:schema targetNamespace="http://ir.catalystbiosciences.com/20220818" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:cbio="http://ir.catalystbiosciences.com/20220818" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="cbio-20220818_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="cbio-20220818_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2022" schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>cbio-20220818_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.7.2.5062 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>cbio-20220818_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.7.2.5062 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="cbio-20220818.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140212342308080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 18, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 18,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-51173<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CATALYST BIOSCIENCES, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001124105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">56-2020050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">611 Gateway Blvd, Suite 710<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">South San Francisco<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">871-0761<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CBIO<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>brhc10041057_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cbio-20220818.xsd" xlink:type="simple"/>
    <context id="c20220818to20220818">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124105</identifier>
        </entity>
        <period>
            <startDate>2022-08-18</startDate>
            <endDate>2022-08-18</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20220818to20220818"
      id="Fact_6644283189c6493d8852ac87ae305779">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20220818to20220818"
      id="Fact_b2e129b36b124c65bf318047ef78c84a">0001124105</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20220818to20220818"
      id="Fact_3204267b8d6646feb9d4c5d04ebeaa03">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20220818to20220818"
      id="Fact_db83e61ebee9430cb481a5fc3f95b847">2022-08-18</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20220818to20220818"
      id="Fact_de1d1d84b0c84df9ae7a5ed69e89be8b">CATALYST BIOSCIENCES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20220818to20220818"
      id="Fact_9c2e43013af049a8a4fabe5174e900d3">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20220818to20220818"
      id="Fact_74c50385d3f841e58993bc8c2fae387a">000-51173</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20220818to20220818"
      id="Fact_b56115757e924c8180834dc75a1497af">56-2020050</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20220818to20220818"
      id="Fact_de59ee36179f4ee8a53a4bafdee7af49">611 Gateway Blvd, Suite 710</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20220818to20220818"
      id="Fact_aebbebe7b27c411289e14c2355b7dd07">South San Francisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20220818to20220818"
      id="Fact_d9c09fde118d4120bf795280f5d5a847">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20220818to20220818"
      id="Fact_e95ad50c2b81421096440a3bd2e8dcd4">94080</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20220818to20220818"
      id="Fact_2ce1ecfb90cc463d84848c66ac5e9914">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20220818to20220818"
      id="Fact_d671054e6f994e0a818d09800b0a2d45">871-0761</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20220818to20220818"
      id="Fact_83d19f365e3d4169ab23f73a8293b8c5">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20220818to20220818"
      id="Fact_1bab9b798b76421db6f6bfc0bd775135">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20220818to20220818"
      id="Fact_0ae1ba9c29b04c28bfea156edb0b678a">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20220818to20220818"
      id="Fact_9dd5575f7c6148b08d750d5c8d400658">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20220818to20220818"
      id="Fact_51454fcffd5c4c6e9964803150da6a88">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20220818to20220818"
      id="Fact_359b14bedb1447e9a6856db0e4763616">CBIO</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20220818to20220818"
      id="Fact_6303330463e242c4b4fd9445e61f2a40">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20220818to20220818"
      id="Fact_0636e19b1b87467e98d6a8d3487dc284">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M@1Z^,NI207&??Y01Q&2^D1E6*UI$!GUZZ?5[%".JBP4]JUI,4Z[6(EN33Z
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ML0(  .(,   -    >&PO<W1Y;&5S+GAM;-U7;6O;,!#^*T(_8&YB:N*1&+9
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M8*<D3?,\C@ 69Y"F& *G$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#!!0
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M8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ I$D359E<G",0!@  G"<  !,
M             ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M" "D21-5E)824E($  "3$   &               @($."   >&PO=V]R:W-H
M965T<R]S:&5E=#$N>&UL4$L! A0#%     @ I$D359^@&_"Q @  X@P   T
M             ( !E@P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " "D21-5
MEXJ[',     3 @  "P              @ %R#P  7W)E;',O+G)E;'-02P$"
M% ,4    " "D21-5'#AEZC\!   \ @  #P              @ %;$   >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ I$D3520>FZ*M    ^ $  !H
M         ( !QQ$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ I$D35660>9(9 0  SP,  !,              ( !K!(  %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  ]A,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="brhc10041057_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="brhc10041057_8k.htm">brhc10041057_8k.htm</File>
    <File>brhc10041057_ex99-1.htm</File>
    <File>cbio-20220818.xsd</File>
    <File>cbio-20220818_lab.xml</File>
    <File>cbio-20220818_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "brhc10041057_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "brhc10041057_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cbio-20220818_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cbio-20220818_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cbio-20220818.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 29,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "cbio",
   "nsuri": "http://ir.catalystbiosciences.com/20220818",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10041057_8k.htm",
      "contextRef": "c20220818to20220818",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10041057_8k.htm",
      "contextRef": "c20220818to20220818",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001140361-22-030333-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-22-030333-xbrl.zip
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MU[<,5R>.8VK8=VQ,=<6T;3='W7UZ38/CEE^05)JLB"L33,<M$&9]+TDBBN,
M1Z 53N2OHUX%INT@GL= :(L!P,AP-(P)O?] %R50/8VJFNOIEJ=JAF^97@!@
M*X9- ]OQ'0/O!O4$%D*%QJIB;D#5JR*1T8 RR4HG1T)O];G42- UDGJL/V%R
M%."Y3M%_]YZ35EXL6/>XQ</I+ )$'/6J?63#E<>0KSR9,_DF]70_GX[$0.UT
M\GI4(JYX"XEX#T+*D!R/UFJ7P?!#%1WKC4^*3]7>9X"MA!1OH)U9>@:L?2*
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M+_#=ZFLHFQ# 80*$(3#8[=$"B4HMT6+'1[TC=AX<$5@/*_5FY?"/J]\_LWT
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M5$?CNX#MUPX8<,LP*JB<\C' ']SE C-NJHEE)$ZJ9#@=K&9Y+8[MDP[K".Z
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MQHLHFE)F6MT/ >#M=P+6S'%4>6LS,'#;#A-I%@K&,OHOI8%+XJCR,"7^A+M
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MM \6=T.>PC0X'9EB@? @U^P>=;N_S+-K!4F,%1&<(EE@^S)\(",M4A0L&"N
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M+=N\.C=YRB"DD<,W38?.847!4)UFNLNR>8HWD9!!S9:4K]0?>J[FYF2LXW<
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M?*5CC"BE0\V%KQ&I)P^B=)NFYH"A"T=(LI&3 +E9^DKF??5Y,,B(Y3*]6H,
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MSX]!' ]#%PY&MH+N2?_ME'TY.SM^4GGW#[2&L_X1RY:X?7&WV635)LJ8,>C
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MS?F94^HX8WE=8\C<8DEBB:F7-[262(BYS1<WOES\9H;NI5%F2[5/VI&AITZ
MH8HXN=FK;8O)_QYD\"L_AGLB/IX3D2Q<LEEAHM0=LUU2N&#*M9##,MO0-AI)
MY2B5SGXCXGS";V$/5T?L(@RB<H5BGDHQ*]"N>(J;/; 7<!+*JK#6,RAPED+8
MB!:2"VQP)M5Q%TGRW/C,,Z+D!/EF1U0:37LPM/F@,:C5.MUNN]-I"6Y7&W:U
M67\"<??I1-P_>"A\O,':,+-!<79U1]::Q-D5-WF/'+O+EMC1H770H4JK7K>[
MW6[=:0#AJ3C=5K,^X$V[9=<K\(_X:>C0C&RP?,F@ZE%CY?3ZG!3Y$3M ]3+*
ML-&DN.V1Q"<%L!(.'P_:182X;/T/K8,RK\;23)3RHG:S+Y:2E]#EDKT019>_
MS1'$1Y/PAUDIUGW4JN$?ZZVEI_"+SL3[-TK!G7JM-6PX=J,KFIUAUVZUZAU'
M='BGQ5=D3&;MB$6I7WDT)'127]%;;R1C,7=9@DK+4KJUHD]:!.HC8/F$JI]3
MQ?--\9)Z_9[B ZJ<WAQFK!X*TWN[Z*FUU3%8]X750)^]KW- 70K)QD\/R47:
MS'U3R)J@6$^22@0=!^-Q 'I6'-C?S>Z+BQ4F14!7"&ZC:>]K[_A\H+A:Y!YM
M+FV=@)5R+^Y\+-*_S':70_H=^4C>G5,!P*6)QXY.W^\EP?STN?%E.W(\"[":
M56NTK4:C)FORSC&@KW]>MN_ZMI=0E<U]]X!5K6J]:C7;[2VO@YH;.FXH[!C(
MG+&H9J6R;9#06H"'P6( /PYD%>=]5T*GVK0ZK>;6UB*W+I?$L9PKX\.AZ[G4
M\QK8K)G1=["U5:VU@-1/1AIK-<#H#YZ(;2POV[L5?B(L=I6X<*+-2G5>S.;:
MU_$A"&-V)F!N?.YW;"8_995VI=;8VA*NA2<FH\"';VJ5ZF&S6SNL-RJ5;4V/
MJO[AF+L>%J[&()=_AF*<1)YG']G!>"</K!'42V8>[R2#6="E/$?S@FU=CWV3
M]VC67,IC=F1^%GKU#I#Y<W;&QSQD[X/$$[<\=#2AKVV/RO6P)K]OL6OQ P2(
M=J?=;#T!?6^W*X<=H.^M1JVQ-3%%4?<M\A-,^#Q*$S[_:=M).%)4;Q%/V=!J
M2N6T,M_%G&N\XVQ+<+9[DJEV+.U^EK8UCN8'K(RIO=TV:QV8-CVMV_6B2,2,
M,DOF9D6MGT;& 2L1SG:JY$NX1SM5<J=*_G1(7\Q'V3'=YVUAOH_I;HW3E#)=
M:K898.V/+:UB+'2G4=U;=*&O9"-KH(KBAMRZX_8OX@(OYO9;.\/YW'YK2]AQ
M^Y\%Z>_-*MJQ^C+;8\=J;=]ONC,8/P9\0$#9MR-VQK\+1=RW=G#ON1>[XR $
MDOZ9AU,/Y8-:M5;=&D$UZ'FC43^L=UJ'E?J3T',G #KSSQL^'O.ZYSV&G"\*
M6-]E#OUTF4,K!ZMM))R;<Z?C5"IVL];H-!J#>J<M&JUJK=-NUVRGVQWLPKGS
MT8'G@7^X"^G>-M1W(=V[D.Y=2/=.;-Z%=#\;0)<DSF^**#]O,6'OW2*]>G=#
M2^R6U1K[%[=M'@;L)'1O0<L\!O!%WUW/L]CY[UM3<ROM5FUKL4\];(8>NP$,
MLL3-V8:5M-VL'%8:U:W%KF, 4E]JU:MQR!L>3O\Y24)1E?JWXH<[6KZVHWE
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MT_./UVGUI*NOU\=GIQ\^]+=@.?KYP-[SQ ^.EG_4;ZZYQT/7@9<:E2;[%(#
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M+3(P,C(P.#$X+GAS9%!+ 0(4 Q0    ( *1)$U58LES*?P@  '18   5
M          "  1EC  !C8FEO+3(P,C(P.#$X7VQA8BYX;6Q02P$"% ,4
M" "D21-5R5#63>8%   -/P  %0              @ '+:P  8V)I;RTR,#(R
B,#@Q.%]P<F4N>&UL4$L%!@     %  4 2P$  .1Q      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
